This study constructed a validated nomogram based on age, AJCC T stage, Ki67 index before NACT, HER2, and HR status, which can be non-invasively applied to personalize the prediction of pCR in BC patients treated with NACT both before NACT and before surgery. The gene discussed is ERBB2; the disease is breast cancer.